Published in Int J Surg Pathol on July 01, 2008
Gastrointestinal stromal tumor. World J Surg Oncol (2009) 2.05
A gist of gastrointestinal stromal tumors: A review. World J Gastrointest Oncol (2013) 1.72
The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study. BMC Cancer (2014) 0.98
Incidence and survival analysis of gastrointestinal stromal tumors in shanghai: a population-based study from 2001 to 2010. Gastroenterol Res Pract (2014) 0.86
Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations. Clin Sarcoma Res (2013) 0.81
Synchronous gastrointestinal cancer and gastrointestinal stromal tumors: a single-institution experience. World J Surg Oncol (2016) 0.79
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model. BMC Cancer (2014) 0.76
Surgical management of gastrointestinal stromal tumors: a single centre's experience. Hippokratia (2015) 0.75
Accomplishments in 2008 in the management of gastrointestinal stromal tumors. Gastrointest Cancer Res (2009) 0.75
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science (2010) 5.84
Weekend versus weekday admission and mortality from gastrointestinal hemorrhage caused by peptic ulcer disease. Clin Gastroenterol Hepatol (2008) 2.89
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis (2011) 2.62
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol (2008) 2.57
Bowel obstruction following appendectomy: what is the true incidence? Ann Surg (2009) 2.50
Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med (2012) 2.08
The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis (2013) 2.05
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol (2010) 2.04
Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm Bowel Dis (2014) 2.03
Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol (2002) 1.85
The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. Exp Physiol (2012) 1.85
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis (2010) 1.84
A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol (2009) 1.84
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood (2010) 1.83
Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology (2010) 1.83
Depression in epilepsy: a systematic review and meta-analysis. Neurology (2012) 1.80
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology (2013) 1.79
Assessment of endoscopic training of general surgery residents in a North American health region. Gastrointest Endosc (2008) 1.71
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology (2010) 1.61
Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol (2005) 1.56
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J (2013) 1.54
Predicting in-hospital mortality in patients undergoing complex gastrointestinal surgery: determining the optimal risk adjustment method. Arch Surg (2011) 1.54
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 1.48
Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice. J Hepatol (2011) 1.48
Isolated visceral small artery fibromuscular hyperplasia-induced ischemic colitis mimicking inflammatory bowel disease. Am J Gastroenterol (2004) 1.45
Laparoscopic versus open resection for colorectal cancer: a metaanalysis of oncologic outcomes. J Am Coll Surg (2007) 1.36
PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest (2008) 1.35
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis (2010) 1.31
Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol (2011) 1.29
Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis (2013) 1.25
Microscopic colitis -- a common cause of diarrhoea in older adults. Age Ageing (2010) 1.24
Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol (2011) 1.24
Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium. J Immunol (2012) 1.22
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol (2011) 1.21
The role of TNFalpha in ulcerative colitis. J Clin Pharmacol (2007) 1.20
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19
The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol (2012) 1.17
Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology (2009) 1.17
Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol (2008) 1.13
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.12
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut (2009) 1.07
Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr (2013) 1.07
Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One (2013) 1.07
Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis (2013) 1.05
Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology (2010) 1.04
Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Can J Gastroenterol Hepatol (2015) 1.03
Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol (2004) 1.01
A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci U S A (2010) 1.01
Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.00
Mitogen-activated protein kinase pathways contribute to hypercontractility and increased Ca2+ sensitization in murine experimental colitis. Mol Pharmacol (2009) 0.98
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One (2012) 0.98
The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol (2012) 0.98
Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology (2011) 0.97
Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int (2011) 0.96
Postoperative complications following colectomy for ulcerative colitis: a validation study. BMC Gastroenterol (2012) 0.96
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol (2010) 0.95
Postoperative complications following colectomy for ulcerative colitis in children. J Pediatr Gastroenterol Nutr (2012) 0.95
Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov (2009) 0.94
TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A (2013) 0.94
The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations. Can J Gastroenterol Hepatol (2014) 0.94
Emergency department visits for migraine and headache: a multi-city study. Int J Occup Med Environ Health (2009) 0.93
Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.93
Recognition of microscopic colitis at colonoscopy. Can J Gastroenterol (2012) 0.93
CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis. Hepatology (2005) 0.93
Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J Innate Immun (2011) 0.92
Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment . Ann Hepatol (2012) 0.92
Octreotide treatment of massive hemorrhage due to cytomegalovirus colitis. Can J Gastroenterol (2003) 0.91
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. Inflamm Bowel Dis (2014) 0.90
Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis. J Mol Med (Berl) (2009) 0.90
The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells. Mediators Inflamm (2012) 0.90
Amoebic liver abscess in USA: a population-based study of incidence, temporal trends and mortality. Liver Int (2011) 0.90
Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Infect Immun (2012) 0.89
Ambient sulphur dioxide exposure and emergency department visits for migraine in Vancouver, Canada. Int J Occup Med Environ Health (2009) 0.89
Clostridium difficile-associated colitis. Can Fam Physician (2004) 0.88
Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.87
Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol (2010) 0.86
Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4. PLoS One (2013) 0.85
Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study. Inflamm Bowel Dis (2014) 0.84
Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis (2014) 0.84
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management. Can J Gastroenterol (2003) 0.84
Clostridium difficile infection worsens the prognosis of ulcerative colitis. Can J Gastroenterol Hepatol (2014) 0.84
Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2015) 0.84
Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun (2011) 0.83
Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83
Invasive amoebiasis: a review of Entamoeba infections highlighted with case reports. Can J Gastroenterol Hepatol (2014) 0.83
Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis. Inflamm Bowel Dis (2007) 0.83
Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis (2009) 0.83
The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction. PLoS One (2013) 0.82
Characteristics of patients with cirrhosis who are discharged from the hospital against medical advice. Clin Gastroenterol Hepatol (2009) 0.82
The association between celiac disease and eosinophilic esophagitis in children and adults. BMC Gastroenterol (2013) 0.82